The proposal would let patients get Wegovy, Ozempic and related drugs for obesity, which Medicare and Medicaid does not cover ...
CMS proposes changes to Medicare and Medicaid to cover weight-loss drugs, recognizing obesity as a disease. This could expand ...
Under the proposal, only those who are considered obese — someone who has a body mass index of 30 or higher — would qualify ...
The proposed rule could give millions of Americans access to the new drugs; it will also put pressure on the incoming Trump administration.